BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report)'s share price was up 7.1% during trading on Friday . The stock traded as high as $11.00 and last traded at $10.82. Approximately 43,477 shares changed hands during mid-day trading, a decline of 30% from the average daily volume of 61,929 shares. The stock had previously closed at $10.10.
BioStem Technologies Price Performance
The firm has a fifty day simple moving average of $13.88 and a two-hundred day simple moving average of $13.87. The firm has a market capitalization of $171.72 million, a P/E ratio of 15.15 and a beta of -0.39.
About BioStem Technologies
(
Get Free Report)
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
Read More
Before you consider BioStem Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioStem Technologies wasn't on the list.
While BioStem Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
